ACCESSION: MSBNK-SMB_Measured-HSA014P0145022
RECORD_TITLE: Characterized; L-Glutamine; LC-ESI-QFT; MS2; NEGATIVE; generated fron DDA dataset
DATE: 2025.04.02 (Averaged 2025.02.21, Processed 2025.02.21, Annotated 2025.03.31, Curated 2025.04.02)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Ruggiero et al. Int J Cancer. 2023, 153, 1, 210-223
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: The metabolite structure was characterized at Level 3 automatically. One of the possible structures is shown in the record.
COMMENT: REPOSITORY MetaboLights
COMMENT: DATASET_ID MTBLS6402
COMMENT: DATASET_TITLE FSCN1 as a new druggable target in adrenocortical carcinoma
COMMENT: DATASET_AUTHORS Andrei Turtoi, Enzo Lalli
COMMENT: MS1_M/Z_AVERAGED_THRES 5.000
COMMENT: MS2_M/Z_AVERAGED_THRES 5.000
COMMENT: DATASET_FILE_NUM 27
COMMENT: NUM_AVERAGED_SPEC 23
COMMENT: RAW_SPEC {'EL20-neg_1018': {'bp': 332626.0, 'sum': 1645900.0}, 'EL12-neg_1021': {'bp': 197533.0, 'sum': 972870.0}, 'EL09-neg_1015': {'bp': 218109.0, 'sum': 1069877.0}, 'EL22-neg_1018': {'bp': 260303.0, 'sum': 1281267.0}, 'EL23-neg_1020': {'bp': 200818.0, 'sum': 998594.0}, 'EL15-neg_1019': {'bp': 240649.0, 'sum': 1246983.0}, 'EL07-neg_1014': {'bp': 248821.0, 'sum': 1213026.0}, 'EL05-neg_1015': {'bp': 261035.0, 'sum': 1372161.0}, 'EL06-neg_1018': {'bp': 302592.0, 'sum': 1523106.0}, 'EL16-neg_1010': {'bp': 250865.0, 'sum': 1194406.0}, 'EL24-neg_1010': {'bp': 259683.0, 'sum': 1269805.0}, 'EL13-neg_1015': {'bp': 227730.0, 'sum': 1128585.0}, 'EL08-neg_1011': {'bp': 264673.0, 'sum': 1297478.0}, 'EL18-neg_1008': {'bp': 208142.0, 'sum': 964421.0}, 'EL14-neg_1010': {'bp': 225797.0, 'sum': 1129498.0}, 'EL11-neg_1009': {'bp': 200127.0, 'sum': 933528.0}, 'EL04-neg_1013': {'bp': 264512.0, 'sum': 1313430.0}, 'EL01-neg_1010': {'bp': 226671.0, 'sum': 1165006.0}, 'EL03-neg_1013': {'bp': 259513.0, 'sum': 1397905.0}, 'EL17-neg_1010': {'bp': 229518.0, 'sum': 1159210.0}, 'EL21-neg_1013': {'bp': 310466.0, 'sum': 1462381.0}, 'EL19-neg_1014': {'bp': 276008.0, 'sum': 1385149.0}, 'EL02-neg_1020': {'bp': 291317.0, 'sum': 1497588.0}}
COMMENT: RETENTION_TIME_STDEV 0.004
COMMENT: PRECURSOR_M/Z_RAW 145.060631
COMMENT: PRECURSOR_M/Z_STDEV 0.000059
COMMENT: PRECURSOR_IN_MS1 mz 145.060901; int 165.840; delta(ppm) 2.580627
COMMENT: PROPOSED_CHARGE_STATE -1; mz 146.064174; int 8.964; cor 0.896
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_ION_FORM M-H; M-H2O-H; mz 127.050154; int 7.810; cor 0.915
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SIRIUS5_Sirius 67.679; C5H10N2O3; [M-H]-; delta(ppm) -6.664521
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C5H10N2O3; [M-H]-; delta(ppm) -6.664521
COMMENT: PROPOSED_MF SIRIUS6_Sirius 99.406; C5H10N2O3; [M-H]-; delta(ppm) -6.664521
COMMENT: PROPOSED_MF SIRIUS6_Sirius 91.654; C3H8N5O2; [M-H]-; delta(ppm) 2.591303
COMMENT: PROPOSED_MF SIRIUS6_Sirius 79.420; C5H6B2N2O2; [M-H]-; delta(ppm) 160156.305970
COMMENT: PROPOSED_MF SIRIUS6_Sirius 24.081; CH6N8O; [M-H]-; delta(ppm) 11.847298
COMMENT: PROPOSED_MF SIRIUS6_Sirius 8.373; C3H5B2F3N2; [M-H]-; delta(ppm) 160178.995161
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C5H10N2O3; [M-H]-; delta(ppm) -6.664521
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.928; CXISPYVYMQWFLE-UHFFFAOYNA-N; [M-H]-; CC(N)C(=O)NCC(O)=O
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.860; CFRMVEKWKKDNAH-VKHMYHEASA-N; [M-H]-; CNC(=O)C[C@H](N)C(O)=O
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.822; ZDXPYRJPNDTMRX-VKHMYHEASA-N; [M-H]-; N[C@@H](CCC(N)=O)C(O)=O
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.766; QDHYJVJAGQLHBA-UHFFFAOYSA-N; [M-H]-; NCCC(=O)NCC(O)=O
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.733; QDILBYVMDFZEFI-UHFFFAOYSA-N; [M-H]-; O=C(O)CCC(O)=NCN
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -43.663; CXISPYVYMQWFLE; [M-H]-; Alanylglycine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -46.446; ZDXPYRJPNDTMRX; [M-H]-; glutamin
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -70.130; QDHYJVJAGQLHBA; [M-H]-; beta-Alanylglycine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -79.927; AEFLONBTGZFSGQ; [M-H]-; |A-glutamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -111.042; CFRMVEKWKKDNAH; [M-H]-; N(4)-methylasparagine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -116.463; XOYSDPUJMJWCBH; [M-H]-; 3,5-diamino-5-oxopentanoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -128.228; VQVHCAXHYBLRIF; [M-H]-; beta-Methyl-asparagine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -128.342; YSPAKPPINKSOKX; [M-H]-; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -146.748; YOKCETMQAPIAGM; [M-H]-; Gly-betaAla
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -156.682; VPZXBVLAVMBEQI; [M-H]-; Glcylalanine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -159.606; VDQFWSAIURVIGH; [M-H]-; N2-acetylserinamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -161.281; QDILBYVMDFZEFI; [M-H]-; N-(Aminomethyl)succinamic acid
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -163.080; QYTWIMMLQKHPGL; [M-H]-; 4-ureidobutanoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -164.024; VYAMLSCELQQRAE; [M-H]-; Gly-Sarcosin
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -175.251; JNBAANABXDTZJY; [M-H]-; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -177.446; MXEGHMONPVXZCB; [M-H]-; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -184.479; YKPKXMAVLXBQDT; [M-H]-; Ethyl ureidoacetate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -187.434; XWBUDPXCXXQEOU; [M-H]-; methyl asparaginate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -192.813; PHENTZNALBMCQD; [M-H]-; beta-Uba
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -197.137; OPVPFHGQNVWIEH; [M-H]-; N~5~-Hydroxy-L-Ornithine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -222.827; WVJOGYWFVNTSAU; [M-H]-; Zeset S
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -232.551; PSXXKGJXVFZKFB; [M-H]-; methyl-carbamoyl-D-alanine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -232.957; HCPOCMMGKBZWSJ; [M-H]-; ACMC-20akzl
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -236.821; FMXWPTBQTITILA; [M-H]-; N-Carbamyl-|A-aminoisobutyric acid
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -245.487; SJLBIPLIGYWGJV; [M-H]-; Nitrosomethyl-3-carboxypropylamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -250.246; RAUQLNDTFONODT; [M-H]-; Ethylnitrosourethan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -263.601; JVRYDNOVFYKHND; [M-H]-; (3R,4R,5R)-3-(hydroxymethyl)-3,4,5,6-tetrahydropyridazine-4,5-diol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -265.065; CJTCFFRJBBMUBJ; [M-H]-; propyl N-carbamoylcarbamate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -266.283; OSABMSLCGCTLLC; [M-H]-; 4,5-dimethoxyimidazolidin-2-one
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -266.637; NRUKNRPYMNPMRU; [M-H]-; 3-pyridazinecarboxylic acid,hexahydro-5-hydroxy-
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -267.583; WJDYAEIVFPVODA; [M-H]-; ethyl 3-amino-3-hydroxyiminopropanoate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -271.639; LGJMYGMNWHYGCB; [M-H]-; 4,3-dimethyl-2-imidazalidinone
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -288.465; IIGUXNQRQSATOU; [M-H]-; Sarcosine, ethyl ester
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -320.927; MMAVGZKLTAOVSO; [M-H]-; Acetoxymethylethylnitrosamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -359.681; HUESNBGSDPNMHU; [M-H]-; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.225; CXISPYVYMQWFLE; [M-H]-; Alanylglycine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -51.673; ZDXPYRJPNDTMRX; [M-H]-; Hgln
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -98.239; AEFLONBTGZFSGQ; [M-H]-; 4,5-Diamino-5-oxopentanoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -109.561; CXISPYVYMQWFLE; [M-H]-; 2-(2-aminopropanamido)acetic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -119.748; OPVPFHGQNVWIEH; [M-H]-; (2S,5E)-2-amino-5-hydroxyiminopentanoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -163.557; QDHYJVJAGQLHBA; [M-H]-; 2-(3-Aminopropanoylamino)acetate
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -168.701; XOYSDPUJMJWCBH; [M-H]-; (3S)-3,5-Diamino-5-oxopentanoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -220.057; VDQFWSAIURVIGH; [M-H]-; N~2~-Acetyl-L-serinamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -224.130; YSPAKPPINKSOKX; [M-H]-; 2-amino-3-acetamidopropanoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -225.840; JNBAANABXDTZJY; [M-H]-; (2S)-4-amino-2-(aminomethyl)-4-oxobutanoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -230.215; VQVHCAXHYBLRIF; [M-H]-; (2S)-2,4-diamino-3-(deuteriomethyl)-4-oxobutanoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.731; ZDXPYRJPNDTMRX; [M-H]-; Hgln
COMMENT: CONFIDENCE Level 3: Tentative candidate, L-Glutamine, ZDXPYRJPNDTMRX-VKHMYHEASA-N; Proposed by SIRIUS6_Confidence with FDR < 0.1; Supported by other software with ranking <= 10 CFM-ID:MsfinderDB (3); This structural isomer was suggested from the biological context HMDB HMDB0000641;HMDB0003423;
CH$COMPOUND_CLASS: Natural product
CH$FORMULA: C5H10N2O3
CH$EXACT_MASS: 146.069142
CH$SMILES: C(CC(=O)N)[C@@H](C(=O)O)N
CH$IUPAC: InChI=1S/C5H10N2O3/c6-3(5(9)10)1-2-4(7)8/h3H,1-2,6H2,(H2,7,8)(H,9,10)/t3-/m0/s1
CH$LINK: CHEBI CHEBI:17061
CH$LINK: HMDB HMDB0000641
CH$NAME: Glutamine
CH$NAME: Glutamine
CH$NAME: L-Glutamine
CH$NAME: (2S)-2,5-diamino-5-oxopentanoic acid
CH$LINK: INCHIKEY ZDXPYRJPNDTMRX-VKHMYHEASA-N
CH$LINK: PUBCHEM CID:5961
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Cell
AC$INSTRUMENT: Vanquish Flex UHPLC system, Thermo Fisher Scientific - Orbitrap Q Exactive Plus mass spectrometer, Thermo Fisher Scientific
AC$INSTRUMENT_TYPE: LC-ESI-QFT
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE NEGATIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY Ramped collision energies of 40 V
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 5.00; MS2(ppm) 5.00
AC$CHROMATOGRAPHY: COLUMN_NAME ZORBAX Pursuit 3 PFP (3 µm, 2.0 mm x 150 mm; Agilent Technologies)
AC$CHROMATOGRAPHY: FLOW_GRADIENT The gradient profile was linear decrease from 0-25% B from 0-2 min; fast linear increase from 25-35% B from 2-11 min; 95% B hold from 15-20 min;fast linear decrease from 95-0% B from 20-21 min. 
AC$CHROMATOGRAPHY: RETENTION_TIME 1.741
MS$FOCUSED_ION: ION_TYPE [M-H]-
MS$FOCUSED_ION: PRECURSOR_M/Z 145.060899
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-004i-5900000000-11bbb464bd8088186403
PK$ANNOTATION: m/z int m/z_nocal m/z_std(ppm) int_std cor n annotation
  58.0284318 176.4630 58.028407 0.7238 17.48 0.8083 23 ?
  67.0287339 97.2183 67.028713 0.7907 13.83 0.6567 22 ?
  70.0283362 28.2537 70.028317 1.1138 5.63 0.4386 19 ?
  72.0076440 95.0426 72.007627 0.9721 17.50 0.4012 23 ?
  74.0233282 340.5032 74.023312 0.4323 43.94 0.7283 23 ?
  82.0284107 140.8052 82.028402 0.9265 14.99 0.8024 23 ?
  84.0440574 563.8137 84.044050 0.4045 35.34 0.9121 23 ?
  86.0232984 85.5250 86.023293 1.0927 12.47 0.6374 23 ?
  97.0392923 46.6547 97.039301 1.3397 9.08 0.5020 22 ?
  98.0233374 55.2549 98.023347 0.9079 11.53 0.6093 22 ?
  99.0549986 69.3410 99.055010 1.0802 13.20 0.7211 22 ?
  101.0706440 196.3942 101.070658 0.6530 15.31 0.8834 23 ?
  102.0546677 29.5901 102.054683 1.3522 17.79 0.0368 17 ?
  107.0237612 70.2099 107.023785 1.1026 9.57 0.4466 23 ?
  109.0393701 417.2532 109.039397 0.6236 35.60 0.8725 23 ?
  110.0427440 27.4625 110.042773 1.4722 6.59 0.5877 19 ?
  125.0343562 164.4517 125.034413 1.0477 22.45 0.6868 23 ?
  127.0499993 999.0000 127.050061 0.4880 0.00 0.9002 23 ?
  128.0340411 458.3423 128.034105 0.5624 40.46 0.8785 23 f{C5H6N1O3}/-9.96ppm,p-H3N1
  128.0535414 61.4639 128.053605 1.2339 12.20 0.7312 21 ?
  145.0606969 533.8486 145.060802 0.4963 30.49 1.0000 23 f{C5H9N2O3}/-8.06ppm,p
PK$NUM_PEAK: 21
PK$PEAK: m/z int. rel.int.
  58.028432 176.46 176
  67.028734 97.22 97
  70.028336 28.25 28
  72.007644 95.04 95
  74.023328 340.50 340
  82.028411 140.81 140
  84.044057 563.81 563
  86.023298 85.53 85
  97.039292 46.65 46
  98.023337 55.25 55
  99.054999 69.34 69
  101.070644 196.39 196
  102.054668 29.59 29
  107.023761 70.21 70
  109.039370 417.25 417
  110.042744 27.46 27
  125.034356 164.45 164
  127.049999 999.00 999
  128.034041 458.34 458
  128.053541 61.46 61
  145.060697 533.85 533
//
